D
Daniel P. Fishbein
Researcher at University of Washington
Publications - 41
Citations - 9040
Daniel P. Fishbein is an academic researcher from University of Washington. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 17, co-authored 35 publications receiving 8436 citations. Previous affiliations of Daniel P. Fishbein include Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure
Gust H. Bardy,Kerry L. Lee,Daniel B. Mark,Jeanne E. Poole,Douglas L. Packer,Robin Boineau,Michael J. Domanski,Charles Troutman,Jill Anderson,Steven McNulty,Nancy E. Clapp-Channing,Linda Davidson-Ray,Elizabeth S. Fraulo,Daniel P. Fishbein,Richard M. Luceri,John Ip +15 more
TL;DR: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.
Journal ArticleDOI
Prognostic importance of defibrillator shocks in patients with heart failure.
Jeanne E. Poole,George Johnson,Anne S. Hellkamp,Jill Anderson,David J. Callans,Merritt H. Raitt,Ramakota K. Reddy,Francis E. Marchlinski,Raymond Yee,Thomas Guarnieri,Mario Talajic,David J. Wilber,Daniel P. Fishbein,Douglas L. Packer,Daniel B. Mark,Kerry L. Lee,Gust H. Bardy +16 more
TL;DR: Among patients with heart failure in whom an ICD is implanted for primary prevention, those who receive shocks for any arrhythmia have a substantially higher risk of death than similar patients who do not receive such shocks.
Journal ArticleDOI
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.
Kevin D. O'Brien,Margaret D. Allen,Thomas O. McDonald,Alan Chait,John M. Harlan,Daniel P. Fishbein,John M. McCarty,Marina S. Ferguson,Kelly L. Hudkins,Christopher D. Benjamin +9 more
TL;DR: The results document the presence of VCAM-1 in human atherosclerosis, demonstrate VCAM1 expression by human smooth muscle cells in vivo, and suggest that intimal neovasculature may be an important site of inflammatory cell recruitment into advanced coronary lesions.
Journal ArticleDOI
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
Wayne C. Levy,Kerry L. Lee,Anne S. Hellkamp,Jeanne E. Poole,Dariush Mozaffarian,David T. Linker,Aldo P. Maggioni,Inder S. Anand,Philip A. Poole-Wilson,Daniel P. Fishbein,George Johnson,Jill Anderson,Daniel B. Mark,Gust H. Bardy +13 more
TL;DR: A clinical risk prediction model identified subsets of moderately symptomatic heart failure patients in SCD-HeFT in whom single-lead ICD therapy was of no benefit and other subsets in which benefit was substantial.
Journal ArticleDOI
Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure
Milton Packer,William T. Abraham,Mandeep R. Mehra,Clyde W. Yancy,Christine E. Lawless,Judith E. Mitchell,Frank W. Smart,Rachel Bijou,Christopher M. O'Connor,Barry M. Massie,Ileana L. Piña,Barry H. Greenberg,James B. Young,Daniel P. Fishbein,Paul J. Hauptman,Robert C. Bourge,John E. Strobeck,Srinvivas Murali,Douglas D. Schocken,John R. Teerlink,Wayne C. Levy,Robin J. Trupp,Marc A. Silver +22 more
TL;DR: Results suggest that when performed at regular intervals in stable patients with HF with a recent episode of clinical decompensation, ICG can identify patients at increased near-term risk of recurrent decompensation.